Human TRIM5α Expression Levels and Reduced Susceptibility to HIV‐1 Infection
Open Access
- 1 June 2009
- journal article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 199 (11), 1657-1663
- https://doi.org/10.1086/598861
Abstract
BackgroundHuman TRIM5α (TRIM5αhu), a member of the tripartite motif protein family, displays some anti–human immunodeficiency virus type 1 (HIV-1) activity in vitro, although it is substantially less potent than its rhesus monkey counterpart (TRIM5αrh). The effects of levels of TRIM5αhu on prevention or control of HIV-1 infection in vivo are unknown MethodsWe used a quantitative real-time polymerase chain reaction (PCR) assay to measure levels of TRIM5αhu expression in peripheral blood mononuclear cells (PBMCs) obtained from a cohort of individuals at high risk for HIV-1 infection in Durban, South Africa. Samples were available from 38 infected subjects (with all these samples obtained within 1 year of infection) and from 57 uninfected persons. Matched preinfection and postinfection samples were available from 13 individuals ResultsTRIM5αhu messenger RNA levels were lower in the PBMCs of HIV-1–infected subjects than in those of uninfected subjects (P<.001). Seroconverters had lower preinfection levels of TRIM5αhu than did nonseroconverters (P<.001). TRIM5αhu levels did not change significantly after infection. There was no correlation between TRIM5αhu levels and viral loads or CD4+ T cell counts ConclusionsHigh expression of TRIM5αhu is associated with reduced susceptibility to HIV-1 infection. Furthermore, infection is not associated with disregulation of TRIM5αhu. TRIM5αhu expression levels do not contribute to the control of primary HIV-1 viremiaKeywords
This publication has 24 references indexed in Scilit:
- Role of APOBEC3G/F-Mediated Hypermutation in the Control of Human Immunodeficiency Virus Type 1 in Elite SuppressorsJournal of Virology, 2008
- The presence of the Trim5α escape mutation H87Q in the capsid of late stage HIV-1 variants is preceded by a prolonged asymptomatic infection phaseAIDS, 2007
- Alpha Interferon Enhances TRIM5α-Mediated Antiviral Activities in Human and Rhesus Monkey CellsJournal of Virology, 2007
- Human Immunodeficiency Virus Controllers: Mechanisms of Durable Virus Control in the Absence of Antiretroviral TherapyImmunity, 2007
- Rhesus monkey TRIM5α restricts HIV-1 production through rapid degradation of viral Gag polyproteinsNature Medicine, 2007
- The Human TRIM5α Restriction Factor Mediates Accelerated Uncoating of the N-Tropic Murine Leukemia Virus CapsidJournal of Virology, 2007
- Effects of human TRIM5α polymorphisms on antiretroviral function and susceptibility to human immunodeficiency virus infectionVirology, 2006
- Intracellular restriction factors in mammalian cells--An ancient defense system finds a modern foe.Current HIV Research, 2006
- Genetic Association of the Antiviral Restriction Factor TRIM5α with Human Immunodeficiency Virus Type 1 InfectionJournal of Virology, 2006
- APOBEC3F and APOBEC3G mRNA Levels Do Not Correlate with Human Immunodeficiency Virus Type 1 Plasma Viremia or CD4 + T-Cell CountJournal of Virology, 2006